Summary
• Modular Medical, Inc. (MODD) shares rise 14.9% to $0.3972 following a $4.68 million public offering announcement.
• The offering includes 12,173,000 shares priced at $0.38 and warrants for an additional 6,086,500 shares.
• Despite today’s gains, MODD remains down 74.8% year-to-date, reflecting ongoing market challenges.
Modular Medical, Inc. (NASDAQ:MODD) is experiencing a notable 14.9% increase in intraday trading, with shares currently priced at $0.3972. This rise comes after the company priced a $4.68 million public offering earlier this week, generating investor interest amid a challenging market backdrop.
Public Offering Announcement Sparks Interest
On December 10, 2025, Modular Medical announced the pricing of its underwritten public offering, which includes 12,173,000 shares of common stock along with warrants for an additional 6,086,500 shares. The effective price for the offering is set at $0.38 per share and $0.01 per warrant. This strategic move aims to raise capital and further develop its insulin delivery technology aimed at adult “almost-pumpers.”
Despite the uptick in share price, MODD remains in a precariously low position year-to-date, down 74.8% overall. The latest public offering pricing has buoyed market sentiment, contributing to today’s price action.
Market Data Snapshot
Currently, the stock has shown a trading volume of 494,136, which is above its average volume of 930,536 over the last 10 days. This reflects a heightened interest level from investors as shares move amidst recent news.
Technical indicators currently show a 14-day relative strength index (RSI) of 34.73, pointing to oversold conditions. The stock’s performance metrics illustrate a turbulent trajectory over the past year, highlighted by a staggering 79.4% drop from its 52-week high.
Regulatory Filings
Modular Medical also filed an 8-K on December 11, 2025, reporting the details surrounding the public offering. This filing follows closely on the heels of its previous announcements regarding the offering and is expected to assist in maintaining transparency with shareholders as the company navigates this capital raise.
Outlook
As traders engage with the public offering news, the company’s next steps will be crucial in determining market momentum. Investors will be closely watching how successfully Modular Medical utilizes this funding to enhance its product offerings and market positioning in the competitive diabetes management sector.